Publication:
Mesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats

Simple item page
dc.contributor.authorIsik, Ahmet Turan
dc.contributor.authorCelik, Turgay
dc.contributor.authorURAL, Ali Ugur
dc.contributor.authorTosun, Murat
dc.contributor.authorULUSOY, Gokhan
dc.contributor.authorElibol, BİRSEN
dc.contributor.institutionauthorELİBOL, BİRSEN
dc.date.accessioned2019-10-05T22:17:34Z
dc.date.available2019-10-05T22:17:34Z
dc.date.issued2016-01-01
dc.description.abstractBackground and Aim: Bone marrow-derived mesenchymal stem cells (BM-MSCs) are one of the sources of adult stem cells being explored for potential use in repairing neurodegenerative disorders. In this study, it was aimed to investigate the useful effects of BM-MSCs therapy on the streptozotocin-induced neurodegeneration in rats.
dc.description.sponsorshipTürkiye Bilimsel Ve Teknolojik Araştırma Kurumu ( Tübitak )
dc.identifier10.1016/j.jocn.2005.09.020
dc.identifier.citationIsik A. T. , Celik T., URAL A. U. , Tosun M., ULUSOY G., Elibol B., -Mesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats-, NEUROLOGICAL RESEARCH, cilt.38, ss.364-372, 2016
dc.identifier.pubmed27078696
dc.identifier.urihttps://hdl.handle.net/20.500.12645/9319
dc.language.isoen
dc.titleMesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameJOURNAL OF CLINICAL NEUROSCIENCE
local.avesis.ide7d0d300-80fb-40db-996d-8beade223aae
local.avesis.response9195
relation.isAuthorOfPublication1b1887fb-6b32-44b1-9d9f-416616dc6734
relation.isAuthorOfPublication.latestForDiscovery1b1887fb-6b32-44b1-9d9f-416616dc6734
Files
Collections
Yayınlar - Eserler
Tıp Fakültesi